Skip to content
healthcare.dev
Get a free key

temozolomide

NDC 75834-145, temozolomide, capsule, from Nivagen Pharmaceuticals, Inc..

Product NDC
75834-145
Status
Listed
Labeler
Nivagen Pharmaceuticals, Inc.
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA213328
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/75834-145 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TEMOZOLOMIDE180 mg/1

Pharmacologic classes

Alkylating Activity [MoA]; Alkylating Drug [EPC]

Package NDCNDC-11Package
75834-145-05758340145051 CARTON in 1 CARTON (75834-145-05) / 5 CAPSULE in 1 CARTON
75834-145-14758340145141 CARTON in 1 CARTON (75834-145-14) / 14 CAPSULE in 1 CARTON

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/27e5a781-e4f2-4489-9def-7971d0b86d9c

Use it

Look up 75834-145 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/75834-145 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 75834-145. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.